|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.82 ZAR | -3.54% |
|
-0.74% | +25.71% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 65.19B 4.02B 3.49B 3.26B 2.98B 5.6B 384B 5.7B 38.27B 14.99B 192B 15.1B 14.78B 641B | P/E 2026 * |
14.9x | P/E 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 78.07B 4.82B 4.17B 3.91B 3.57B 6.71B 459B 6.82B 45.83B 17.96B 230B 18.09B 17.69B 767B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.63x |
| Free-Float |
59.64% | Yield 2026 * |
1.81% | Yield 2027 * | 1.71% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | -3.54% | ||
| 1 week | -0.74% | ||
| Current month | -1.53% | ||
| 1 month | -2.80% | ||
| 3 months | +2.58% | ||
| 6 months | +34.64% | ||
| Current year | +25.71% |
| 1 week | 146.82 |  | 154.04 |
| 1 month | 142.6 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 382.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.54% | -0.74% | +33.04% | -26.02% | 4.02B | |
| -0.18% | -0.12% | +19.44% | +70.83% | 48.85B | |
| -2.51% | +3.73% | +55.57% | +121.11% | 41.43B | |
| +0.01% | +0.32% | -3.82% | +18.44% | 12.39B | |
| -0.42% | +5.62% | +23.91% | +84.54% | 12.46B | |
| 0.00% | -0.38% | +30.98% | +136.36% | 9.08B | |
| +1.95% | +9.12% | +25.38% | +40.22% | 7.53B | |
| -0.41% | +4.61% | +39.74% | -13.28% | 7.14B | |
| +0.52% | +1.13% | +11.00% | +186.40% | 6.73B | |
| -1.22% | +4.46% | -25.04% | +29.64% | 5.88B | |
| Average | -0.62% | +3,387.89% | +21.02% | +64.82% | 15.55B | |
| Weighted average by Cap. | -0.84% | +4,891.47% | +27.77% | +80.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.32B 2.01B 1.88B 1.72B 3.23B 221B 3.29B 22.08B 8.65B 111B 8.72B 8.53B 370B | 38.86B 2.4B 2.08B 1.95B 1.78B 3.34B 229B 3.4B 22.81B 8.94B 114B 9B 8.81B 382B |
| Net income | 4.8B 296M 257M 240M 219M 412M 28.24B 419M 2.82B 1.1B 14.13B 1.11B 1.09B 47.16B | 5B 308M 267M 250M 228M 429M 29.4B 437M 2.93B 1.15B 14.72B 1.16B 1.13B 49.1B |
| Net Debt | 12.88B 795M 689M 645M 588M 1.11B 75.79B 1.13B 7.56B 2.96B 37.94B 2.98B 2.92B 127B | -1.74B -107M -92.79M -86.87M -79.26M -149M -10.21B -152M -1.02B -399M -5.11B -402M -393M -17.05B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | ZAR 146.82 | -3.54% | 1,983,587 |
| 26-08-07 | ZAR 152.21 | -0.09% | 1,248,880 |
| 26-08-06 | ZAR 152.35 | +3.09% | 1,301,229 |
| 26-08-05 | ZAR 147.78 | -0.09% | 549,573 |
| 26-08-04 | ZAR 147.92 | +0.82% | 1,107,536 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
